IDH-mutant and 1p/19q codeleted grade-3 oligodendrogliomas have a dramatically longer overall survival median when treated with radiotherapy and PCV in comparison to only radiotherapy treatment. This evidence concerns the gene IDH1 and oligodendroglioma.